ANX005

· Annexon, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ANX005, covering 2023-01-31 to 2026-08-25. Get the full timeline:

Most recent: Clinical Trial Results: An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's Disease [Phase 2]